Clinicians at Froedtert & the Medical College of Wisconsin Clinical Cancer Center are achieving excellent planning results in the first US combination of Elekta’s Monaco® 5 radiotherapy treatment planning software and Siemens’ mARC (modulated arc) therapy technique. The Froedtert & the Medical College team treated their first patient, an individual with prostate cancer, using the combination of Monaco 5 and mARC on March 26.
Milwaukee, WI United States — Friday, May 2, 2014“mARC is a form of volumetric modulated arc therapy [VMAT], which has significant advantages over step-and-shoot IMRT in radiotherapy delivery speed and/or dose conformity, so we were eager to get mARC working on our Siemens treatment machine,” says X. Allen Li, PhD, Chief Physicist, Department of Radiation Oncologyat Froedtert & the Medical College of Wisconsin Clinical Cancer Center. “The first case was a complex two-arc plan for treating both pelvic nodes and prostate bed, but on pre-treatment verification we achieved 99 percent agreement between the measured dose distribution and the plan dose distribution, which is very good. And, we’ve been able to replicate this accuracy in most of cases measured so far.”
###
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242
Email: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time